Geneos Wealth Management Inc. Sells 2,675 Shares of Lam Research Corporation $LRCX

Geneos Wealth Management Inc. reduced its holdings in Lam Research Corporation (NASDAQ:LRCX) by 68.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,246 shares of the semiconductor company’s stock after selling 2,675 shares during the period. Geneos Wealth Management Inc.’s holdings in Lam Research were worth $167,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research in the second quarter valued at about $26,000. Howard Hughes Medical Institute bought a new position in Lam Research in the second quarter valued at approximately $27,000. Strategic Wealth Investment Group LLC bought a new stake in shares of Lam Research during the 2nd quarter worth approximately $29,000. Delos Wealth Advisors LLC bought a new stake in shares of Lam Research during the 2nd quarter worth approximately $30,000. Finally, REAP Financial Group LLC acquired a new stake in shares of Lam Research in the 2nd quarter valued at approximately $31,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Price Performance

Lam Research stock opened at $218.36 on Monday. The company has a market capitalization of $274.27 billion, a price-to-earnings ratio of 48.10, a PEG ratio of 2.52 and a beta of 1.77. The stock’s 50 day moving average is $165.99 and its 200-day moving average is $133.33. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $219.59.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm’s quarterly revenue was up 27.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd were paid a $0.26 dividend. The ex-dividend date was Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.5%. Lam Research’s payout ratio is 22.91%.

Insider Buying and Selling at Lam Research

In related news, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the sale, the chief financial officer directly owned 987,237 shares in the company, valued at approximately $148,677,892.20. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Bethany Mayer sold 1,298 shares of the stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total value of $207,667.02. Following the sale, the director directly owned 1,652 shares in the company, valued at $264,303.48. This represents a 44.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 50,418 shares of company stock valued at $7,667,305 in the last quarter. Company insiders own 0.31% of the company’s stock.

Analysts Set New Price Targets

LRCX has been the topic of a number of recent analyst reports. The Goldman Sachs Group restated a “buy” rating and set a $180.00 target price on shares of Lam Research in a report on Friday. Wall Street Zen downgraded shares of Lam Research from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Needham & Company LLC lifted their price target on Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Cowen restated a “buy” rating on shares of Lam Research in a research note on Thursday, October 23rd. Finally, Susquehanna lifted their target price on Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research note on Thursday, October 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $164.37.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.